November 16, 2026
Business

Mankind Pharma gets CDSCO nod for Phase 1 trials for novel autoimmune drug(Soban News)

Mankind Pharma has received CDSCO approval to initiate Phase 1 trials of MKP11093, a novel JAK-1 inhibitor for autoimmune disorders, as part of its expanding R&D pipeline

​Mankind Pharma has received CDSCO approval to initiate Phase 1 trials of MKP11093, a novel JAK-1 inhibitor for autoimmune disorders, as part of its expanding R&D pipeline by Soban News (international And National News)

Related posts

Gold rises but investors stay cautious about ‘hawkish’ Fed tone(Soban News)

News-Soban-Admin

Vodafone Idea shares jump 5% as telco set to consider fundraise on May 16. What lies ahead?(Soban News)

News-Soban-Admin

Anthropic unveils faster, cheaper Claude AI models as it gears up for mega IPO – The Times of India(Soban News)

News-Soban-Admin

Leave a Comment